Donor regulatory T lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-013141
Donor-derived regulatory T-cells (Tregs), with potential immunomodulating activity. Tregs are a subset of CD4+ T cells that express high levels of CD25 (interleukin 2 receptor) and the transcription factor Foxp3. The donor CD4+CD25+ Tregs modulate immune responses and may induce tolerance to allogeneic organ transplants, such as hematopoietic stem cell transplants (HSCTs), thereby preventing graft-versus-host disease (GVHD).
| Identifier | MLC-T-ONC-013141 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | donor CD4+CD25+FoxP3+ T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013141",
"term": "Donor regulatory T lymphocytes",
"field": "Oncology and biomedicine",
"definition": "Donor-derived regulatory T-cells (Tregs), with potential immunomodulating activity. Tregs are a subset of CD4+ T cells that express high levels of CD25 (interleukin 2 receptor) and the transcription factor Foxp3. The donor CD4+CD25+ Tregs modulate immune responses and may induce tolerance to allogeneic organ transplants, such as hematopoietic stem cell transplants (HSCTs), thereby preventing graft-versus-host disease (GVHD).",
"synonyms": [
"donor CD4+CD25+FoxP3+ T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/donor-regulatory-t-lymphocytes/"
}
Record 6,175 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.